CORT has been in the news 900% more than usual
Dec 31, 2025, 3:31 PM
0.71%
What does CORT do
Corcept Therapeutics, based in Menlo Park, California, is a commercial-stage pharmaceutical company that markets Korlym for Cushing's syndrome and has a portfolio of selective cortisol modulators. Founded in 2004, it employs 352 people and offers around 1,000 compounds.
CORT has been in the news recently: On December 29, Robb, the Chief Business Officer at Corcept Therapeutics, exercised stock options, which was reported in a significant SEC filing. Following the FDA's rejection of its drug relacorilant, Corcept Therapeutics' stock experienced a notable decline.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.